GLP-1s (glucagon-like peptide-1 receptor agonists) were originally developed to manage type 2 diabetes by improving blood sugar control
Check at baseline, 6-8 weeks after starting, after each 10-15 pounds of weight loss, every 3-4 months during active weight loss, and every 6 months after weight stabilization
Assessors achieved reliability with each other before beginning the assessment process to minimize sources of error
If using insurance, most plans cover FDA-approved medications, including Zepbound and Mounjaro
Patients should be encouraged to report any suspected side effects via the MHRA Yellow Card Scheme
To obtain the values for the average number of seizures per week, this calculation was achieved by tallying all the patients recorded seizures in the past 12 weeks and dividing the total number by 12